კრონის დაავადება

წყაროები

ძირითადი სტატიები

Ooi CJ, Makharia GK, Hilmi I, et al. Asia Pacific consensus statements on Crohn's disease. Part 1: Definition, diagnosis, and epidemiology. J Gastroenterol Hepatol. 2016 Jan;31(1):45-55.სრული ტექსტი  აბსტრაქტი

Gomollón F, Dignass A, Annese V, et al. 3rd European evidence-based consensus on the diagnosis and management of Crohn's disease 2016: Part 1: Diagnosis and medical management. J Crohns Colitis. 2017 Jan;11(1):3-25.სრული ტექსტი  აბსტრაქტი

Lichtenstein GR, Loftus EV, Isaacs KL, et al. ACG clinical guideline: management of Crohn's disease in adults. Am J Gastroenterol. 2018 Apr;113(4):481-517.სრული ტექსტი  აბსტრაქტი

Gionchetti P, Dignass A, Danese S, et al. 3rd European evidence-based consensus on the diagnosis and management of Crohn’s disease 2016: Part 2: Surgical management and special situations. J Crohns Colitis. 2017 Feb;11(2):135-49.სრული ტექსტი  აბსტრაქტი

Nguyen GC, Loftus EV Jr, Hirano I, et al; AGA Institute Clinical Guidelines Committee. American Gastroenterological Association Institute guideline on the management of Crohn's disease after surgical resection. Gastroenterology. 2017 Jan;152(1):271-5.სრული ტექსტი  აბსტრაქტი

Farraye FA, Melmed GY, Lichtenstein GR, et al. ACG clinical guideline: preventive care in inflammatory bowel disease. Am J Gastroenterol. 2017 Feb;112(2):241-58.სრული ტექსტი  აბსტრაქტი

გამოყენებული სტატიები

1. Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002 Aug 8;347(6):417-29. აბსტრაქტი

2. Ekbom A, Helmick C, Zack M, et al. The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden. Gastroenterology. 1991 Feb;100(2):350-8. აბსტრაქტი

3. Gasche C, Scholmerich J, Brynskov J, et al. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis. 2000 Feb;6(1):8-15. აბსტრაქტი

4. Baumgart DC, Sandborn WJ. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet. 2007 May 12;369(9573):1641-57. აბსტრაქტი

5. Barreiro-de Acosta M, Domínguez-Muñoz JE, Nuñez-Pardo de Vera MC, et al. Relationship between clinical features of Crohn's disease and the risk of developing extraintestinal manifestations. Eur J Gastroenterol Hepatol. 2007 Jan;19(1):73-8. აბსტრაქტი

6. Irving PM, Pasi KJ, Rampton DS. Thrombosis and inflammatory bowel disease. Clin Gastroenterol Hepatol. 2005 Jul;3(7):617-28. აბსტრაქტი

7. Fraquelli M, Losco A, Visentin S, et al. Gallstone disease and related risk factors in patients with Crohn disease: analysis of 330 consecutive cases. Arch Intern Med. 2001 Oct 8;161(18):2201-4.სრული ტექსტი  აბსტრაქტი

8. Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2018 Dec 23;390(10114):2769-78. აბსტრაქტი

9. Centers for Disease Control and Prevention. Inflammatory bowel disease (IBD). Dec 2019 [internet publication].სრული ტექსტი

10. Shivananda S, Lennard-Jones J, Logan R, et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut. 1996 Nov;39(5):690-7.სრული ტექსტი  აბსტრაქტი

11. Chouraki V, Dauchet L, Vernier-Massouille G, et al. P214 - the changing pattern of Crohn's disease incidence according to age in Northern France: a constant increase in the 0-19 years age group (1988-2005). Abstracts of the 4th Congress of ECCO - the European Crohn’s and Colitis Organisation. Hamburg, Germany, 5-7 February 2009. J Crohn's Colitis. 2009 Feb 1;3(1):S95.სრული ტექსტი

12. Jess T, Riis L, Vind I, et al. Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark. Inflamm Bowel Dis. 2007 Apr;13(4):481-9. აბსტრაქტი

13. Cosnes J, Beaugerie L, Carbonnel F, et al. Smoking cessation and the course of Crohn's disease: an intervention study. Gastroenterology. 2001 Apr;120(5):1093-9. აბსტრაქტი

14. Peeters M, Nevens H, Baert F, et al. Familial aggregation in Crohn's disease: increased age-adjusted risk and concordance in clinical characteristics. Gastroenterology. 1996 Sep;111(3):597-603. აბსტრაქტი

15. Franke A, McGovern D, Barrett JC, et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet. 2010 Dec;42(12):1118-25. აბსტრაქტი

16. Barrett JC, Hansoul S, Nicolae DL, et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet. 2008 Aug;40(8):955-62.სრული ტექსტი  აბსტრაქტი

17. Xu WD, Xie QB, Zhao Y, et al. Association of interleukin-23 receptor gene polymorphisms with susceptibility to Crohn's disease: a meta-analysis. Sci Rep. 2015 Dec 18;5:18584.სრული ტექსტი  აბსტრაქტი

18. Dai YE, Guan R, Song YT. The association of DLG5 polymorphisms with inflammatory bowel disease: a meta-analysis of 25 studies. Eur Rev Med Pharmacol Sci. 2016 Jun;20(11):2324-37.სრული ტექსტი  აბსტრაქტი

19. Maher B. Personal genomes: the case of the missing heritability. Nature. 2008 Nov 6;456(7218):18-21. აბსტრაქტი

20. Joossens M, Simoens M, Vermeire S, et al. Contribution of genetic and environmental factors in the pathogenesis of Crohn's disease in a large family with multiple cases. Inflamm Bowel Dis. 2007 May;13(5):580-4. აბსტრაქტი

21. Lerebours E, Gower-Rousseau C, Merle V, et al. Stressful life events as a risk factor for inflammatory bowel disease onset: a population-based case-control study. Am J Gastroenterol. 2007 Jan;102(1):122-31. აბსტრაქტი

22. Underner M, Perriot J, Cosnes J, et al. Smoking, smoking cessation and Crohn's disease [in French]. Presse Med. 2016 Apr;45(4 Pt 1):390-402. აბსტრაქტი

23. Ortizo R, Lee SY, Nguyen ET, et al. Exposure to oral contraceptives increases the risk for development of inflammatory bowel disease: a meta-analysis of case-controlled and cohort studies. Eur J Gastroenterol Hepatol. 2017 Sep;29(9):1064-70. აბსტრაქტი

24. Bonner GF, Fakhri A, Vennamaneni SR. A long-term cohort study of nonsteroidal anti-inflammatory drug use and disease activity in outpatients with inflammatory bowel disease. Inflamm Bowel Dis. 2004 Nov;10(6):751-7. აბსტრაქტი

25. Felder JB, Korelitz BI, Rajapakse R, et al. Effects of nonsteroidal antiinflammatory drugs on inflammatory bowel disease: a case-control study. Am J Gastroenterol. 2000 Aug;95(8):1949-54. აბსტრაქტი

26. Halfvarson J, Jess T, Magnuson A, et al. Environmental factors in inflammatory bowel disease: a co-twin control study of a Swedish-Danish twin population. Inflamm Bowel Dis. 2006 Oct;12(10):925-33. აბსტრაქტი

27. Danese S, Fiocchi C. Etiopathogenesis of inflammatory bowel diseases. World J Gastroenterol. 2006 Aug 14;12(30):4807-12. აბსტრაქტი

28. Sartor RB. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol. 2006 Jul;3(7):390-407. აბსტრაქტი

29. Heresbach D, Alexandre JL, Branger B, et al. Frequency and significance of granulomas in a cohort of incident cases of Crohn's disease. Gut. 2005 Feb;54(2):215-22.სრული ტექსტი  აბსტრაქტი

30. Pierik M, De Hertogh G, Vermeire S, et al. Epithelioid granulomas, pattern recognition receptors, and phenotypes of Crohn's disease. Gut. 2005 Feb;54(2):223-7.სრული ტექსტი  აბსტრაქტი

31. Fabisiak N, Fabisiak A, Watala C, et al. Fat-soluble vitamin deficiencies and inflammatory bowel disease: systematic review and meta-analysis. J Clin Gastroenterol. 2017 Nov/Dec;51(10):878-89. აბსტრაქტი

32. Lapidus A, Akerlund JE, Einarsson C. Gallbladder bile composition in patients with Crohn's disease. World J Gastroenterol. 2006 Jan 7;12(1):70-4. აბსტრაქტი

33. Lapidus A, Einarsson C. Bile composition in patients with ileal resection due to Crohn's disease. Inflamm Bowel Dis. 1998 May;4(2):89-94. აბსტრაქტი

34. Obialo CI, Clayman RV, Matts JP, et al. Pathogenesis of nephrolithiasis post-partial ileal bypass surgery: case-control study. The POSCH Group. Kidney Int. 1991 Jun;39(6):1249-54. აბსტრაქტი

35. Silverstein MD, Lashner BA, Hanauer SB, et al. Cigarette smoking in Crohn's disease. Am J Gastroenterol. 1989 Jan;84(1):31-3. აბსტრაქტი

36. Boyko EJ, Koepsell TD, Perera DR, et al. Risk of ulcerative colitis among former and current cigarette smokers. N Engl J Med. 1987 Mar 19;316(12):707-10. აბსტრაქტი

37. Calkins BM. A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci. 1989 Dec;34(12):1841-54. აბსტრაქტი

38. Koletzko S, Sherman P, Corey M, et al. Role of infant feeding practices in development of Crohn's disease in childhood. BMJ. 1989 Jun 17;298(6688):1617-8.სრული ტექსტი  აბსტრაქტი

39. Gurzu S, Molnar C, Contac AO, et al. Tuberculosis terminal ileitis: a forgotten entity mimicking Crohn's disease. World J Clin Cases. 2016 Sep 16;4(9):273-80.სრული ტექსტი  აბსტრაქტი

40. Ooi CJ, Makharia GK, Hilmi I, et al. Asia Pacific consensus statements on Crohn's disease. Part 1: Definition, diagnosis, and epidemiology. J Gastroenterol Hepatol. 2016 Jan;31(1):45-55.სრული ტექსტი  აბსტრაქტი

41. Limsrivilai J, Shreiner AB, Pongpaibul A, et al. Meta-analytic Bayesian model for differentiating intestinal tuberculosis from Crohn's disease. Am J Gastroenterol. 2017 Mar;112(3):415-27.სრული ტექსტი  აბსტრაქტი

42. Rispo A, Imbriaco M, Celentano L, et al. Small bowel Crohn's disease: comparison of enteroclysis, bowel sonography and Tc-99m-HMPAO leukocyte scintigraphy. Eur Rev Med Pharmacol Sci. 2004 Sep-Oct;8(5):219-24. აბსტრაქტი

43. Rubesin SE, Scotiniotis I, Birnbaum BA, et al. Radiologic and endoscopic diagnosis of Crohn's disease. Surg Clin North Am. 2001 Feb;81(1):39-70, viii. აბსტრაქტი

44. Ahmed O, Rodrigues DM, Nguyen GC. Magnetic resonance imaging of the small bowel in Crohn's disease: a systematic review and meta-analysis. Can J Gastroenterol Hepatol. 2016;2016:7857352.სრული ტექსტი  აბსტრაქტი

45. Bruining DH, Zimmermann EM, Loftus EV Jr, et al; Society of Abdominal Radiology Crohn’s Disease-Focused Panel. Consensus recommendations for evaluation, interpretation, and utilization of computed tomography and magnetic resonance enterography in patients with small bowel Crohn's disease. Radiology. 2018 Mar;286(3):776-99.სრული ტექსტი  აბსტრაქტი

46. Greenup AJ, Bressler B, Rosenfeld G. Medical imaging in small bowel Crohn's disease - computer tomography enterography, magnetic resonance enterography, and ultrasound: "which one is the best for what?". Inflamm Bowel Dis. 2016 May;22(5):1246-61. აბსტრაქტი

47. Spier BJ, Perlman SB, Reichelderfer M. FDG-PET in inflammatory bowel disease. Q J Nucl Med Mol Imaging. 2009 Feb;53(1):64-71. აბსტრაქტი

48. Feakins RM; British Society of Gastroenterology. Inflammatory bowel disease biopsies: updated British Society of Gastroenterology reporting guidelines. J Clin Pathol. 2013 Dec;66(12):1005-26.სრული ტექსტი  აბსტრაქტი

49. Argüelles-Arias F, Donat E, Fernández-Urien I, et al. Guideline for wireless capsule endoscopy in children and adolescents: a consensus document by the SEGHNP (Spanish Society for Pediatric Gastroenterology, Hepatology, and Nutrition) and the SEPD (Spanish Society for Digestive Diseases). Rev Esp Enferm Dig. 2015 Dec;107(12):714-31.სრული ტექსტი  აბსტრაქტი

50. van Rheenen PF, Van de Vijver E, Fidler V. Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis. BMJ. 2010 Jul 15;341:c3369.სრული ტექსტი  აბსტრაქტი

51. Kane SV, Sandborn WJ, Rufo PA, et al. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation. Am J Gastroenterol. 2003 Jun;98(6):1309-14. აბსტრაქტი

52. Kopylov U, Yung DE, Engel T, et al. Fecal calprotectin for the prediction of small-bowel Crohn's disease by capsule endoscopy: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2016 Oct;28(10):1137-44. აბსტრაქტი

53. Wang Y, Pei F, Wang X, et al. Diagnostic accuracy of fecal lactoferrin for inflammatory bowel disease: a meta-analysis. Int J Clin Exp Pathol. 2015 Oct 1;8(10):12319-32.სრული ტექსტი  აბსტრაქტი

54. Mao R, Xiao YL, Gao x, et al. Fecal calprotectin in predicting relapse of inflammatory bowel diseases: a meta-analysis of prospective studies. Inflamm Bowel Dis. 2012 Oct;18(10):1894-9. აბსტრაქტი

55. Mosli MH, Zou G, Garg SK, et al. C-reactive protein, fecal calprotectin, and stool lactoferrin for detection of endoscopic activity in symptomatic inflammatory bowel disease patients: a systematic review and meta-analysis. Am J Gastroenterol. 2015 Jun;110(6):802-19. აბსტრაქტი

56. Gisbert JP, McNicholl AG. Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease. Dig Liver Dis. 2009 Jan;41(1):56-66. აბსტრაქტი

57. National Institute for Health and Care Excellence. Faecal calprotectin diagnostic tests for inflammatory diseases of the bowel. May 2017 [internet publication].სრული ტექსტი

58. Yamamoto T, Shimoyama T. Monitoring and detection of disease recurrence after resection for Crohn's disease: the role of non-invasive fecal biomarkers. Expert Rev Gastroenterol Hepatol. 2017 Oct;11(10):899-909. აბსტრაქტი

59. Nordgren S, Fasth S, Hulten L. Anal fistulas in Crohn's disease: incidence and outcome of surgical treatment. Int J Colorectal Dis. 1992 Dec;7(4):214-8. აბსტრაქტი

60. Schwartz DA, Loftus EV Jr, Tremaine WJ, et al. The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota. Gastroenterology. 2002 Apr;122(4):875-80. აბსტრაქტი

61. Lakatos PL, Lakatos L, Kiss LS, et al. Treatment of extraintestinal manifestations in inflammatory bowel disease. Digestion. 2012;86 Suppl 1:28-35. აბსტრაქტი

62. Chamouard P, Richert Z, Meyer N, et al. Diagnostic value of C-reactive protein for predicting activity level of Crohn's disease. Clin Gastroenterol Hepatol. 2006 Jul;4(7):882-7. აბსტრაქტი

63. Horsthuis K, Bipat S, Stokkers PC, et al. Magnetic resonance imaging for evaluation of disease activity in Crohn's disease: a systematic review. Eur Radiol. 2009 Jun;19(6):1450-60. აბსტრაქტი

64. Varela Lema L, Ruano-Ravina A. Effectiveness and safety of capsule endoscopy in the diagnosis of small bowel diseases. J Clin Gastroenterol. 2008 May-Jun;42(5):466-71. აბსტრაქტი

65. Zholudev A, Zurakowski D, Young W, et al. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype. Am J Gastroenterol. 2004 Nov;99(11):2235-41. აბსტრაქტი

66. Sandborn WJ, Loftus EV Jr, Colombel JF, et al. Utility of perinuclear anti-neutrophil cytoplasmic antibodies (pANCA), anti-saccharomyces cerevesiae (ASCA), and anti-pancreatic antibodies (APA) as serologic markers in a population based cohort of patients with Crohn's disease (CD) and ulcerative colitis (UC). Abstract 696. Paper presented at: 101st Annual Meeting of the American Gastroenterological Association, 21-24 May 2000. Gastroenterology. 2000 Apr;118(4):A106.სრული ტექსტი

67. Granito A, Zauli D, Muratori P, et al. Anti-Saccharomyces cerevisiae and perinuclear anti-neutrophil cytoplasmic antibodies in coeliac disease before and after gluten-free diet. Aliment Pharmacol Ther. 2005 Apr 1;21(7):881-7.სრული ტექსტი  აბსტრაქტი

68. Matsumoto T, Iida M, Matsui T, et al. Endoscopic findings in Yersinia enterocolitica enterocolitis. Gastrointest Endosc. 1990 Nov-Dec;36(6):583-7. აბსტრაქტი

69. Sturm A, Maaser C, Calabrese E, et al; European Crohn’s and Colitis Organisation [ECCO] and the European Society of Gastrointestinal and Abdominal Radiology [ESGAR]. ECCO-ESGAR guideline for diagnostic assessment in IBD Part 2: IBD scores and general principles and technical aspects. J Crohns Colitis. 2019 Mar 26;13(3):273-84.სრული ტექსტი  აბსტრაქტი

70. Best WR, Becktel JM, Singleton JW, et al. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology. 1976 Mar;70(3):439-44. აბსტრაქტი

71. Gomollón F, Dignass A, Annese V, et al. 3rd European evidence-based consensus on the diagnosis and management of Crohn's disease 2016: Part 1: Diagnosis and medical management. J Crohns Colitis. 2017 Jan;11(1):3-25.სრული ტექსტი  აბსტრაქტი

72. Lichtenstein GR, Loftus EV, Isaacs KL, et al. ACG clinical guideline: management of Crohn's disease in adults. Am J Gastroenterol. 2018 Apr;113(4):481-517.სრული ტექსტი  აბსტრაქტი

73. Sandborn WJ, Feagan BG, Hanauer SB, et al. A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease. Gastroenterology. 2002 Feb;122(2):512-30. აბსტრაქტი

74. European Medicines Agency. Guideline on the development of new medicinal products for the treatment of Crohn's disease. Jun 2018 [internet publication].სრული ტექსტი

75. Farmer RG, Whelan G, Fazio VW. Long-term follow-up of patients with Crohn's disease. Relationship between the clinical pattern and prognosis. Gastroenterology. 1985 Jun;88(6):1818-25. აბსტრაქტი

76. Bermejo F, Aguas M, Chaparro M, et al; en representación de GETECCU. Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the use of thiopurines in inflammatory bowel disease. Gastroenterol Hepatol. 2018 Mar;41(3):205-21.სრული ტექსტი  აბსტრაქტი

77. Keane J, Gershon S, Wise RP, et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med. 2001 Oct 11;345(15):1098-104.სრული ტექსტი  აბსტრაქტი

78. Esteve M, Saro C, González-Huix F, et al. Chronic hepatitis B reactivation following infliximab therapy in Crohn’s disease patients: need for primary prophylaxis. Gut. 2004 Sep;53(9):1363-5.სრული ტექსტი  აბსტრაქტი

79. Lemaitre M, Kirchgesner J, Rudnichi A et al. Association between use of thiopurines or tumor necrosis factor antagonists alone or in combination and risk of lymphoma in patients with inflammatory bowel disease. JAMA. 2017 Nov 7;318(17):1679-86.სრული ტექსტი  აბსტრაქტი

80. MacDonald JK, Nguyen TM, Khanna R, et al. Anti-IL-12/23p40 antibodies for induction of remission in Crohn's disease. Cochrane Database Syst Rev. 2016 Nov 25;(11):CD007572.სრული ტექსტი  აბსტრაქტი

81. Engel T, Ungar B, Yung DE, et al. Vedolizumab in IBD - lessons from real-world experience; a systematic review and pooled analysis. J Crohns Colitis. 2018 Jan 24;12(2):245-57.სრული ტექსტი  აბსტრაქტი

82. National Institute for Health and Care Excellence. Medicines evidence commentary: biosimilar infliximab - a successful managed switch programme in people with inflammatory bowel disease. Apr 2017 [internet publication].სრული ტექსტი  აბსტრაქტი

83. ClinicalTrials.gov. Program evaluating the autoimmune disease investigational drug cT-p13 in RA patients (PLANETRA). NCT01217086. Mar 2013 [internet publication].სრული ტექსტი

84. ClinicalTrials.gov. Program evaluating the autoimmune disease investigational drug cT-p13 in AS patients (PLANETAS). NCT01220518. Mar 2013 [internet publication].სრული ტექსტი

85. Jørgensen KK, Olsen IC, Goll GL, et al; NOR-SWITCH Study Group. Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial. Lancet. 2017 Jun 10;389(10086):2304-16. აბსტრაქტი

86. Kuenzig ME, Rezaie A, Seow CH, et al. Budesonide for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev. 2014 Aug 21;(8):CD002913.სრული ტექსტი  აბსტრაქტი

87. Bonovas S, Nikolopoulos GK, Lytras T, et al. Comparative safety of systemic and low-bioavailability steroids in inflammatory bowel disease: systematic review and network meta-analysis. Br J Clin Pharmacol. 2018 Feb;84(2):239-51. აბსტრაქტი

88. Rezaie A, Kuenzig ME, Benchimol EI, et al. Budesonide for induction of remission in Crohn's disease. Cochrane Database Syst Rev. 2015 Jun 3;(6):CD000296.სრული ტექსტი  აბსტრაქტი

89. Sandborn WJ, Feagan BG, Lichtenstein GR. Medical management of mild to moderate Crohn's disease: evidence-based treatment algorithms for induction and maintenance of remission. Aliment Pharmacol Ther. 2007 Oct 1;26(7):987-1003.სრული ტექსტი  აბსტრაქტი

90. Narula N, Dhillon A, Zhang D, et al. Enteral nutritional therapy for induction of remission in Crohn's disease. Cochrane Database Syst Rev. 2018 Apr 1;(4):CD000542.სრული ტექსტი  აბსტრაქტი

91. Hanauer SB, Strömberg U. Oral Pentasa in the treatment of active Crohn's disease: a meta-analysis of double-blind, placebo-controlled trials. Clin Gastroenterol Hepatol. 2004 May;2(5):379-88. აბსტრაქტი

92. Lim WC, Wang Y, MacDonald JK, et al. Aminosalicylates for induction of remission or response in Crohn's disease. Cochrane Database Syst Rev. 2016 Jul 3;(7):CD008870.სრული ტექსტი  აბსტრაქტი

93. Kane SV, Schoenfeld P, Sandborn WJ, et al. The effectiveness of budesonide therapy for Crohn's disease. Aliment Pharmacol Ther. 2002 Aug;16(8):1509-17. აბსტრაქტი

94. Summers RW, Switz DM, Sessions JT Jr, et al. National Cooperative Crohn's Disease Study: results of drug treatment. Gastroenterology. 1979 Oct;77(4 Pt 2):847-69. აბსტრაქტი

95. Malchow H, Ewe K, Brandes JW, et al. European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment. Gastroenterology. 1984 Feb;86(2):249-66. აბსტრაქტი

96. Brassard P, Bitton A, Suissa A, et al. Oral corticosteroids and the risk of serious infections in patients with elderly-onset inflammatory bowel diseases. Am J Gastroenterol. 2014 Nov;109(11):1795-802. აბსტრაქტი

97. McDonald JW, Wang Y, Tsoulis DJ, et al. Methotrexate for induction of remission in refractory Crohn's disease. Cochrane Database Syst Rev. 2014 Aug 6;(8):CD003459.სრული ტექსტი  აბსტრაქტი

98. Chande N, Townsend CM, Parker CE, et al. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease. Cochrane Database Syst Rev. 2016 Oct 26;(10):CD000545.სრული ტექსტი  აბსტრაქტი

99. Bebb JR, Scott BB. How effective are the usual treatments for Crohn's disease? Aliment Pharmacol Ther. 2004 Jul 15;20(2):151-9. აბსტრაქტი

100. Sandborn WJ, Faubion WA. Clinical pharmacology of inflammatory bowel disease therapies. Curr Gastroenterol Rep. 2000 Dec;2(6):440-5. აბსტრაქტი

101. Steinhart AH, Ewe K, Griffiths AM, et al. Corticosteroids for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev. 2003;(4):CD000301. აბსტრაქტი

102. Lichtenstein GR, Abreu MT, Cohen R, et al; American Gastroenterological Association. American Gastroenterological Association Institute medical position statement on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease. Gastroenterology. 2006 Mar;130(3):935-9.სრული ტექსტი  აბსტრაქტი

103. Peyrin-Biroulet L, Deltenre P, de Suray N, et al. Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: meta-analysis of placebo-controlled trials. Clin Gastroenterol Hepatol. 2008 Jun;6(6):644-53. აბსტრაქტი

104. Cholapranee A, Hazlewood GS, Kaplan GG, et al. Systematic review with meta-analysis: comparative efficacy of biologics for induction and maintenance of mucosal healing in Crohn's disease and ulcerative colitis controlled trials. Aliment Pharmacol Ther. 2017 May;45(10):1291-302.სრული ტექსტი  აბსტრაქტი

105. Hazlewood GS, Rezaie A, Borman M, et al. Comparative effectiveness of immunosuppressants and biologics for inducing and maintaining remission in Crohn's disease: a network meta-analysis. Gastroenterology. 2015 Feb;148(2):344-54.e5. აბსტრაქტი

106. Ford AC, Peyrin-Biroulet L. Opportunistic infections with anti-tumor necrosis factor-alpha therapy in inflammatory bowel disease: meta-analysis of randomized controlled trials. Am J Gastroenterol. 2013 Aug;108(8):1268-76. აბსტრაქტი

107. Nanda KS, Cheifetz AS, Moss AC. Impact of antibodies to infliximab on clinical outcomes and serum infliximab levels in patients with inflammatory bowel disease (IBD): a meta-analysis. Am J Gastroenterol. 2013 Jan;108(1):40-7.სრული ტექსტი  აბსტრაქტი

108. Nielsen OH, Bjerrum JT, Seidelin JB, et al. Biological treatment of Crohn's disease. Dig Dis. 2012;30 Suppl 3:121-33. აბსტრაქტი

109. Regueiro MD. Update in medical treatment of Crohn's disease. J Clin Gastroenterol. 2000 Dec;31(4):282-91. აბსტრაქტი

110. Colombel JF, Rutgeerts P, Reinisch W, et al. P087: SONIC: a randomized, double-blind, controlled trial comparing infliximab and infliximab plus azathrioprine to azathioprine in patients with Crohn’s disease naive to immunomodulators and biologic therapy. Abstracts of the 4th Congress of ECCO - the European Crohn’s and Colitis Organisation; Hamburg, Germany, 5-7 February 2009. J Crohns Colitis. 2009 Feb 1;3(1):S45-6.სრული ტექსტი

111. Colombel JF, Sandborn WJ, Reinisch W, et al; SONIC Study Group. Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med. 2010 Apr 15;362(15):1383-95. აბსტრაქტი

112. Sandborn WJ, Feagan BG, Rutgeerts P, et al; GEMINI 2 Study Group. Vedolizumab as induction and maintenance therapy for Crohn's disease. N Engl J Med. 2013 Aug 22;369(8):711-21.სრული ტექსტი  აბსტრაქტი

113. National Institute for Health and Care Excellence. Vedolizumab for treating moderately to severely active Crohn's disease after prior therapy. Aug 2015 [internet publication].სრული ტექსტი

114. Sandborn WJ, Gasink C, Gao LL, et al; CERTIFI Study Group. Ustekinumab induction and maintenance therapy in refractory Crohn's disease. N Engl J Med. 2012 Oct 18;367(16):1519-28.სრული ტექსტი  აბსტრაქტი

115. Colombel JF, Sands BE, Rutgeerts P, et al. The safety of vedolizumab for ulcerative colitis and Crohn's disease. Gut. 2017 May;66(5):839-51.სრული ტექსტი  აბსტრაქტი

116. National Institute for Health and Care Excellence. Ustekinumab for moderately to severely active Crohn’s disease after previous treatment. Jul 2017 [internet publication].სრული ტექსტი

117. Weston LA, Roberts PL, Schoetz DJ Jr, et al. Ileocolic resection for acute presentation of Crohn's disease of the ileum. Dis Colon Rectum. 1996 Aug;39(8):841-6. აბსტრაქტი

118. Nordgren SR, Fasth SB, Oresland TO, et al. Long-term follow-up in Crohn's disease: mortality, morbidity, and functional status. Scand J Gastroenterol. 1994 Dec;29(12):1122-8. აბსტრაქტი

119. Kim NK, Senagore AJ, Luchtefeld MA, et al. Long-term outcome after ileocecal resection for Crohn's disease. Am Surg. 1997 Jul;63(7):627-33. აბსტრაქტი

120. Graadal O, Nygaard K. Crohn disease: long-term effects of surgical treatment [in Norwegian]. Tidsskr Nor Laegeforen. 1994 May 30;114(14):1603-5. აბსტრაქტი

121. Sandborn WJ, Feagan BG, Stoinov S, et al. Certolizumab pegol for the treatment of Crohn's disease. N Engl J Med. 2007 Jul 19;357(3):228-38.სრული ტექსტი  აბსტრაქტი

122. Colombel JF, Sandborn WJ, Rutgeerts P, et al. Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial. Gastroenterology. 2007 Jan;132(1):52-65. აბსტრაქტი

123. Yamamoto T, Fazio VW, Tekkis PP. Safety and efficacy of strictureplasty for Crohn's disease: a systematic review and meta-analysis. Dis Colon Rectum. 2007 Nov;50(11):1968-86. აბსტრაქტი

124. Reese GE, Purkayastha S, Tilney HS, et al. Strictureplasty vs resection in small bowel Crohn's disease: an evaluation of short-term outcomes and recurrence. Colorectal Dis. 2007 Oct;9(8):686-94. აბსტრაქტი

125. Campbell L, Ambe R, Weaver J, et al. Comparison of conventional and nonconventional strictureplasties in Crohn's disease: a systematic review and meta-analysis. Dis Colon Rectum. 2012 Jun;55(6):714-26. აბსტრაქტი

126. Menon AM, Mirza AH, Moolla S, et al. Adenocarcinoma of the small bowel arising from a previous strictureplasty for Crohn's disease: report of a case. Dis Colon Rectum. 2007 Feb;50(2):257-9. აბსტრაქტი

127. Tremaine WJ. Gastroduodenal Crohn's disease: medical management. Inflamm Bowel Dis. 2003 Mar;9(2):127-8. აბსტრაქტი

128. O'Riordan JM, Datta I, Johnston C, et al. A systematic review of the anal fistula plug for patients with Crohn's and non-Crohn's related fistula-in-ano. Dis Colon Rectum. 2012 Mar;55(3):351-8. აბსტრაქტი

129. Thia KT, Mahadevan U, Feagan BG, et al. Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn's disease: a randomized, double-blind, placebo-controlled pilot study. Inflamm Bowel Dis. 2009 Jan;15(1):17-24. აბსტრაქტი

130. Pearson DC, May GR, Fick GH, et al. Azathioprine and 6-mercaptopurine in Crohn's disease: a meta-analysis. Ann Intern Med 1995 Jul 15;123(2):132-42. აბსტრაქტი

131. Gionchetti P, Dignass A, Danese S, et al. 3rd European evidence-based consensus on the diagnosis and management of Crohn’s disease 2016: Part 2: Surgical management and special situations. J Crohns Colitis. 2017 Feb;11(2):135-49.სრული ტექსტი  აბსტრაქტი

132. Steinhart AH, Panaccione R, Targownik L, et al. Clinical practice guideline for the medical management of perianal fistulizing Crohn's disease: The Toronto Consensus. Inflamm Bowel Dis. 2019 Jan 1;25(1):1-13.სრული ტექსტი  აბსტრაქტი

133. Colombel JF, Schwartz DA, Sandborn WJ, et al. Adalimumab for the treatment of fistulas in patients with Crohn's disease. Gut. 2009 Jul;58(7):940-8.სრული ტექსტი  აბსტრაქტი

134. Dewint P, Hansen BE, Verhey E, et al. Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI). Gut. 2014 Feb;63(2):292-9. აბსტრაქტი

135. Ricart E, Panaccione R, Loftus EV, et al. Infliximab for Crohn's disease in clinical practice at the Mayo Clinic: the first 100 patients. Am J Gastroenterol. 2001 Mar;96(3):722-9. აბსტრაქტი

136. Poritz LS, Rowe WA, Koltun WA. Remicade does not abolish the need for surgery in fistulizing Crohn's disease. Dis Colon Rectum. 2002 Jun;45(6):771-5. აბსტრაქტი

137. Lamb CA, Kennedy NA, Raine T, et al. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019 Dec;68(suppl 3):s1-106.სრული ტექსტი  აბსტრაქტი

138. Rolfe VE, Fortun PJ, Hawkey CJ, et al. Probiotics for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev. 2006 Oct 18;(4):CD004826. აბსტრაქტი

139. Ganji-Arjenaki M, Rafieian-Kopaei M. Probiotics are a good choice in remission of inflammatory bowel diseases: a meta analysis and systematic review. J Cell Physiol. 2018 Mar;233(3):2091-103. აბსტრაქტი

140. Patel V, Wang Y, MacDonald JK, et al. Methotrexate for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev. 2014 Aug 26;(8):CD006884.სრული ტექსტი  აბსტრაქტი

141. Akobeng AK, Zhang D, Gordon M, et al. Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's disease. Cochrane Database Syst Rev. 2016 Sep 28;(9):CD003715.სრული ტექსტი  აბსტრაქტი

142. Huang ML, Ran ZH, Shen J, et al. Efficacy and safety of adalimumab in Crohn's disease: meta-analysis of placebo-controlled trials. J Dig Dis. 2011 Jun;12(3):165-72. აბსტრაქტი

143. Ford AC, Sandborn WJ, Khan KJ, et al. Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol. 2011 Apr;106(4):644-59. აბსტრაქტი

144. National Institute for Health and Care Excellence. Therapeutic monitoring of TNF-alpha inhibitors in Crohn’s disease (LISA-TRACKER ELISA kits, IDKmonitor ELISA kits, and Promonitor ELISA kits). Feb 2016 [internet publication].სრული ტექსტი

145. National Institute for Health and Care Excellence. RIDASCREEN tests for monitoring infliximab in inflammatory bowel disease. Jun 2017 [internet publication].სრული ტექსტი

146. Lin Z, Bai Y, Zheng P. Meta-analysis: efficacy and safety of combination therapy of infliximab and immunosuppressives for Crohn's disease. Eur J Gastroenterol Hepatol. 2011 Nov;23(12):1100-10. აბსტრაქტი

147. Doherty G, Bennett G, Patil S, et al. Interventions for prevention of post-operative recurrence of Crohn's disease. Cochrane Database Syst Rev. 2009 Oct 7;(4):CD006873.სრული ტექსტი  აბსტრაქტი

148. Van Loo ES, Dijkstra G, Ploeg RJ, et al. Prevention of postoperative recurrence of Crohn's disease. J Crohns Colitis. 2012 Jul;6(6):637-46. აბსტრაქტი

149. De Cruz P, Kamm MA, Prideaux L, et al. Postoperative recurrent luminal Crohn's disease: a systematic review. Inflamm Bowel Dis. 2012 Apr;18(4):758-77. აბსტრაქტი

150. Buisson A, Chevaux JB, Allen PB, et al. Review article: the natural history of postoperative Crohn's disease recurrence. Aliment Pharmacol Ther. 2012 Mar;35(6):625-33.სრული ტექსტი  აბსტრაქტი

151. Gjuladin-Hellon T, Gordon M, Iheozor-Ejiofor Z, et al. Oral 5-aminosalicylic acid for maintenance of surgically-induced remission in Crohn's disease. Cochrane Database Syst Rev. 2019 Jun 20;(6):CD008414.სრული ტექსტი  აბსტრაქტი

152. Nguyen GC, Loftus EV Jr, Hirano I, et al; AGA Institute Clinical Guidelines Committee. American Gastroenterological Association Institute guideline on the management of Crohn's disease after surgical resection. Gastroenterology. 2017 Jan;152(1):271-5.სრული ტექსტი  აბსტრაქტი

153. National Institute for Health and Care Excellence. Crohn's disease: management. May 2019 [internet publication].სრული ტექსტი

154. Savarino E, Bodini G, Dulbecco P, et al. Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn's disease: a randomized controlled trial. Am J Gastroenterol. 2013 Nov;108(11):1731-42. აბსტრაქტი

155. Lémann M, Mary JY, Colombel JF, et al. A randomized, double-blind, controlled withdrawal trial in Crohn's disease patients in long-term remission on azathioprine. Gastroenterology. 2005 Jun;128(7):1812-8. აბსტრაქტი

156. Te HS, Schiano TD, Kuan SF, et al. Hepatic effects of long-term methotrexate use in the treatment of inflammatory bowel disease. Am J Gastroenterol. 2000 Nov;95(11):3150-6. აბსტრაქტი

157. Boyapati RK, Torres J, Palmela C, et al. Withdrawal of immunosuppressant or biologic therapy for patients with quiescent Crohn's disease. Cochrane Database Syst Rev. 2018 May 12;(5):CD012540.სრული ტექსტი  აბსტრაქტი

158. Bohn Thomsen S, Kiszka-Kanowitz M, Theede K, et al. Optimized thiopurine therapy before withdrawal of anti-tumour necrosis factor-α in patients with Crohn's disease. Eur J Gastroenterol Hepatol. 2018 Oct;30(10):1155-8. აბსტრაქტი

159. Braun J, Brandt J, Listing J, et al. Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial. Lancet. 2002 Apr 6;359(9313):1187-93. აბსტრაქტი

160. Brooklyn T, Dunnill G, Probert C. Diagnosis and treatment of pyoderma gangrenosum. BMJ. 2006 Jul 22;333(7560):181-4.სრული ტექსტი  აბსტრაქტი

161. Brooklyn TN, Dunnill MG, Shetty A, et al. Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial. Gut. 2006 Apr;55(4):505-9.სრული ტექსტი  აბსტრაქტი

162. Afifi L, Sanchez IM, Wallace MM, et al. Diagnosis and management of peristomal pyoderma gangrenosum: a systematic review. J Am Acad Dermatol. 2018 Jun;78(6):1195-204.e1. აბსტრაქტი

163. Mannon PJ, Fuss IJ, Mayer L, et al. Anti-interleukin-12 antibody for active Crohn's disease. N Engl J Med. 2004 Nov 11;351(20):2069-79. [Erratum in: N Engl J Med. 2005 Mar 24;352(12):1276.]სრული ტექსტი  აბსტრაქტი

164. Reinisch W, Hommes DW, Van Assche G, et al. A dose escalating, placebo controlled, double blind, single dose and multidose, safety and tolerability study of fontolizumab, a humanised anti-interferon gamma antibody, in patients with moderate to severe Crohn's disease. Gut. 2006 Aug;55(8):1138-44. აბსტრაქტი

165. van Deventer SJ, Elson CO, Fedorak RN. Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Crohn's Disease Study Group. Gastroenterology. 1997 Aug;113(2):383-9. აბსტრაქტი

166. Wilhelm SM, Taylor JD, Osiecki LL, et al. Novel therapies for Crohn's disease: focus on immunomodulators and antibiotics. Ann Pharmacother. 2006 Oct;40(10):1804-13. აბსტრაქტი

167. van Dieren JM, Kuipers EJ, Samsom JN, et al. Revisiting the immunomodulators tacrolimus, methotrexate, and mycophenolate mofetil: their mechanisms of action and role in the treatment of IBD. Inflamm Bowel Dis. 2006 Apr;12(4):311-27. აბსტრაქტი

168. Yacyshyn B, Chey WY, Wedel MK, et al. A randomized, double-masked, placebo-controlled study of alicaforsen, an antisense inhibitor of intercellular adhesion molecule 1, for the treatment of subjects with active Crohn's disease. Clin Gastroenterol Hepatol. 2007 Feb;5(2):215-20. აბსტრაქტი

169. Schreiber S, Nikolaus S, Malchow H, et al. Absence of efficacy of subcutaneous antisense ICAM-1 treatment of chronic active Crohn's disease. Gastroenterology. 2001 May;120(6):1339-46. აბსტრაქტი

170. Askari FK, McDonnell WM. Antisense-oligonucleotide therapy. N Engl J Med. 1996 Feb 1;334(5):316-8. აბსტრაქტი

171. Nelson SM, Nguyen TM, McDonald JW, et al. Natalizumab for induction of remission in Crohn's disease. Cochrane Database Syst Rev. 2018 Aug 1;(8):CD006097.სრული ტექსტი  აბსტრაქტი

172. National Institute for Health and Care Excellence. Extracorporeal photopheresis for Crohn's disease. Feb 2009 [internet publication].სრული ტექსტი

173. Korzenik JR, Dieckgraefe BK. An open-labeled study of granulocyte colony-stimulating factor in the treatment of active Crohn's disease. Aliment Pharmacol Ther. 2005 Feb 15;21(4):391-400. აბსტრაქტი

174. Panés J, García-Olmo D, Van Assche G, et al. Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial. Lancet. 2016 Sep 24;388(10051):1281-90. აბსტრაქტი

175. Panés J, García-Olmo D, Van Assche G et al. OP009: long-term efficacy and safety of Cx601, allogeneic expanded adipose-derived mesenchymal stem cells, for complex perianal fistulas in Crohn's disease: 52-week results of a phase III randomised controlled trial. Abstracts of the 12th Congress of ECCO - the European Crohn's and Colitis Organisation. Barcelona, Spain, 15-18 February 2017. J Crohn's Colitis. 2017 Feb;11(suppl 1):S5.სრული ტექსტი

176. National Institute for Health and Care Excellence. Darvadstrocel for treating complex perianal fistulas in Crohn's disease. Jan 2019 [internet publication].სრული ტექსტი

177. Qiu X, Feng JR, Chen LP, et al. Efficacy and safety of autologous hematopoietic stem cell therapy for refractory Crohn's disease: a systematic review and meta-analysis. Medicine (Baltimore). 2017 Jun;96(26):e7381.სრული ტექსტი  აბსტრაქტი

178. Patton PH, Parker CE, MacDonald JK, et al. Anti-tuberculous therapy for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev. 2016 Jul 22;(7):CD000299.სრული ტექსტი  აბსტრაქტი

179. Summers RW, Elliott DE, Urban JF Jr, et al. Trichuris suis therapy in Crohn's disease. Gut. 2005 Jan;54(1):87-90.სრული ტექსტი  აბსტრაქტი

180. Huang X, Zeng LR, Chen FS, et al. Trichuris suis ova therapy in inflammatory bowel disease: a meta-analysis. Medicine (Baltimore). 2018 Aug;97(34):e12087.სრული ტექსტი  აბსტრაქტი

181. Bernell O, Lapidus A, Hellers G. Risk factors for surgery and recurrence in 907 patients with primary ileocaecal Crohn's disease. Br J Surg. 2000 Dec;87(12):1697-701. აბსტრაქტი

182. Murray JJ, Schoetz DJ Jr, Nugent FW, et al. Surgical management of Crohn's disease involving the duodenum. Am J Surg. 1984 Jan;147(1):58-65. აბსტრაქტი

183. Beaugerie L, Seksik P, Nion-Larmurier I, et al. Predictors of Crohn's disease. Gastroenterology. 2006 Mar;130(3):650-6. აბსტრაქტი

184. Weterman IT, Biemond I, Peña AS. Mortality and causes of death in Crohn's disease. Review of 50 years' experience in Leiden University Hospital. Gut. 1990 Dec;31(12):1387-90.სრული ტექსტი  აბსტრაქტი

185. Card R, Hubbard R, Logan RF. Mortality in inflammatory bowel disease: a population-based cohort study. Gastroenterology. 2003 Dec;125(6):1583-90. აბსტრაქტი

186. Jess T, Loftus EV Jr, Harmsen WS, et al. Survival and cause specific mortality in patients with inflammatory bowel disease: a long term outcome study in Olmsted County, Minnesota, 1940-2004. Gut. 2006 Sep;55(9):1248-54. აბსტრაქტი

187. Bernstein CN, Nugent Z, Targownik LE, et al. Predictors and risks for death in a population-based study of persons with IBD in Manitoba. Gut. 2015 Sep;64(9):1403-11. აბსტრაქტი

188. Bettenworth D, Gustavsson A, Atreja A, et al. A pooled analysis of efficacy, safety, and long-term outcome of endoscopic balloon dilation therapy for patients with stricturing Crohn's disease. Inflamm Bowel Dis. 2017 Jan;23(1):133-42. აბსტრაქტი

189. Navaneethan U, Lourdusamy V, Njei B, et al. Endoscopic balloon dilation in the management of strictures in Crohn's disease: a systematic review and meta-analysis of non-randomized trials. Surg Endosc. 2016 Dec;30(12):5434-43. აბსტრაქტი

190. Compston J. Osteoporosis in inflammatory bowel disease. Gut. 2003 Jan;52(1):63-4.სრული ტექსტი  აბსტრაქტი

191. Jess T, Gamborg M, Matzen P, et al. Increased risk of intestinal cancer in Crohn's disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol. 2005 Dec;100(12):2724-9. აბსტრაქტი

192. Jess T, Loftus EV Jr, Velayos FS, et al. Incidence and prognosis of colorectal dysplasia in inflammatory bowel disease: a population-based study from Olmsted County, Minnesota. Inflamm Bowel Dis. 2006 Aug;12(8):669-76. აბსტრაქტი

193. Bernstein CN, Blanchard JF, Kliewer E, et al. Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer. 2001 Feb 15;91(4):854-62.სრული ტექსტი  აბსტრაქტი

194. Connell WR, Sheffield JP, Kamm MA, et al. Lower gastrointestinal malignancy in Crohn's disease. Gut. 1994 Mar;35(3):347-52.სრული ტექსტი  აბსტრაქტი

195. Loftus EV Jr, Tremaine WJ, Habermann TM, et al. Risk of lymphoma in inflammatory bowel disease. Am J Gastroenterol. 2000 Sep;95(9):2308-12. აბსტრაქტი

196. Kandiel A, Fraser AG, Korelitz BI, et al. Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine. Gut. 2005 Aug;54(8):1121-5. აბსტრაქტი

197. Jess T, Horváth-Puhó E, Fallingborg J, et al. Cancer risk in inflammatory bowel disease according to patient phenotype and treatment: a Danish population-based cohort study. Am J Gastroenterol. 2013 Dec;108(12):1869-76. აბსტრაქტი

198. Wang LH, Yang YJ, Cheng WC, et al. Higher risk for hematological malignancies in inflammatory bowel disease: a nationwide population-based study in Taiwan. Am J Gastroenterol. 2016 Sep;111(9):1313-9. აბსტრაქტი

199. Ali T, Yun L, Rubin DT. Risk of post-operative complications associated with anti-TNF therapy in inflammatory bowel disease. World J Gastroenterol. 2012 Jan 21;18(3):197-204.სრული ტექსტი  აბსტრაქტი

200. Khan N, Abbas AM, Whang N, et al. Incidence of liver toxicity in inflammatory bowel disease patients treated with methotrexate: a meta-analysis of clinical trials. Inflamm Bowel Dis. 2012 Feb;18(2):359-67. აბსტრაქტი

201. de Jong MJ, van der Meulen-de Jong AE, Romberg-Camps MJ, et al. Telemedicine for management of inflammatory bowel disease (myIBDcoach): a pragmatic, multicentre, randomised controlled trial. Lancet. 2017 Sep 2;390(10098):959-68. აბსტრაქტი

202. Cao BL, Qasem A, Sharp RC, et al. Systematic review and meta-analysis on the association of tuberculosis in Crohn's disease patients treated with tumor necrosis factor-α inhibitors (Anti-TNFα). World J Gastroenterol. 2018 Jul 7;24(25):2764-75.სრული ტექსტი  აბსტრაქტი

203. Farraye FA, Odze RD, Eaden J, et al. AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology. 2010 Feb;138(2):738-45.სრული ტექსტი  აბსტრაქტი

204. von Roon AC, Reese G, Teare J, et al. The risk of cancer in patients with Crohn's disease. Dis Colon Rectum. 2007 Jun;50(6):839-55. აბსტრაქტი

205. Bye WA, Nguyen TM, Parker CE, et al. Strategies for detecting colon cancer in patients with inflammatory bowel disease. Cochrane Database Syst Rev. 2017 Sep 18;(9):CD000279.სრული ტექსტი  აბსტრაქტი

206. Maykel JA, Hagerman G, Mellgren AF, et al. Crohn's colitis: the incidence of dysplasia and adenocarcinoma in surgical patients. Dis Colon Rectum. 2006 Jul;49(7):950-7. აბსტრაქტი

207. Tu W, Xu G, Du S. Structure and content components of self-management interventions that improve health-related quality of life in people with inflammatory bowel disease: a systematic review, meta-analysis and meta-regression. J Clin Nurs. 2015 Oct;24(19-20):2695-709. აბსტრაქტი

208. Shah S. Dietary factors in the modulation of inflammatory bowel disease activity. MedGenMed. 2007 Mar 27;9(1):60.სრული ტექსტი  აბსტრაქტი

209. Brennan GT, Ha I, Hogan C, et al. Does preoperative enteral or parenteral nutrition reduce postoperative complications in Crohn's disease patients: a meta-analysis. Eur J Gastroenterol Hepatol. 2018 Sep;30(9):997-1002. აბსტრაქტი

210. Grass F, Pache B, Martin D, et al. Preoperative nutritional conditioning of Crohn's patients - systematic review of current evidence and practice. Nutrients. 2017 Jun 1;9(6):E562.სრული ტექსტი  აბსტრაქტი

211. Khalili H, Granath F, Smedby KE, et al. Association between long-term oral contraceptive use and risk of Crohn's disease complications in a nationwide study. Gastroenterology. 2016 Jun;150(7):1561-7.e1.სრული ტექსტი  აბსტრაქტი

212. Farraye FA, Melmed GY, Lichtenstein GR, et al. ACG clinical guideline: preventive care in inflammatory bowel disease. Am J Gastroenterol. 2017 Feb;112(2):241-58.სრული ტექსტი  აბსტრაქტი

213. Eaden JA, Mayberry JF; British Society for Gastroenterology; Association of Coloproctology for Great Britain and Ireland. Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease. Gut. 2002 Oct;51 Suppl 5:V10-2.სრული ტექსტი  აბსტრაქტი

ამ მასალის გამოყენება ექვემდებარება ჩვენს განცხადებას